Wu W S, Holmans P, Wavrant-DeVrièze F, Shears S, Kehoe P, Crook R, Booth J, Williams N, Pérez-Tur J, Roehl K, Fenton I, Chartier-Harlin M C, Lovestone S, Williams J, Hutton M, Hardy J, Owen M J, Goate A
Department of Psychiatry, Washington University School of Medicine, St Louis, MO, USA.
JAMA. 1998 Aug 19;280(7):619-22. doi: 10.1001/jama.280.7.619.
The only genetic locus universally accepted to be important as a risk factor for late-onset Alzheimer disease (AD) is the apolipoprotein E (APOE) locus on chromosome 19. However, this locus does not account for all the risk in late-onset disease, and a recent report has suggested a second locus on chromosome 12p11-12.
To look for evidence of linkage on chromosome 12 and to test for the presence of the new locus in an independent sample of familial late-onset AD cases.
Retrospective cohort study. As part of a 20-centimorgan genome screen (approximately equal to 200 markers), we tested a series of 18 genetic markers on chromosome 12 and carried out multipoint, nonparametric lod score and exclusion analyses.
Clinic populations in the continental United States selected from the National Institute of Mental Health AD Genetics Consortium.
We selected samples for DNA analysis from affected sibling pairs, 497 subjects from 230 families with 2 or more affected individuals with probable or definite AD with onset ages older than 60 years (mean+/-SD, 75+/-6 years). Within the families, we used the 2 probable or definitely affected individuals. In families with more than 2 such cases available, we used all of them; in families with only 2 such cases in which unaffected individuals were available, we also sampled the oldest unaffected individual and used genotype data from this unaffected individual to check for nonpaternity and genotyping errors.
Presence of linkage or locus on chromosome 12.
Although linkage analyses confirmed the presence of a genetic susceptibility factor at the APOE locus in these families with late-onset AD, we were unable to confirm the presence of a locus close to the marker D12S1042. A moderate lod score (1.91) was found near D12S98 close to the alpha2-macroglobulin locus in the affected pairs in which both members did not possess an APOE epsilon4 allele.
APOE remains the only locus established to be a risk factor for late-onset AD. We were unable to confirm that a locus on chromosome 12p11-12 has a major effect on risk for late-onset AD, although an effect smaller than that for APOE cannot be excluded.
普遍认为作为晚发型阿尔茨海默病(AD)风险因素的唯一基因位点是位于19号染色体上的载脂蛋白E(APOE)基因位点。然而,该位点并不能解释晚发型疾病的所有风险,最近有报告指出在12号染色体p11 - 12区域存在第二个基因位点。
寻找12号染色体上连锁的证据,并在家族性晚发型AD病例的独立样本中检测新基因位点的存在情况。
回顾性队列研究。作为20厘摩基因组筛查(约等于200个标记)的一部分,我们检测了12号染色体上的一系列18个遗传标记,并进行了多点、非参数连锁值计算和排除分析。
从美国国立精神卫生研究所AD遗传学联盟中选取的美国大陆临床人群。
我们从患病同胞对中选取样本进行DNA分析,这些样本来自230个家庭的497名受试者,这些家庭中有2名或更多发病年龄大于60岁(平均±标准差,75±6岁)的可能或确诊AD患者。在每个家庭中,我们选取2名可能或确诊患病的个体。在有超过2名此类病例的家庭中,我们使用所有病例;在只有2名此类病例且有未患病个体的家庭中,我们还选取年龄最大的未患病个体,并使用该未患病个体的基因型数据来检查非父系遗传和基因分型错误。
12号染色体上连锁或基因位点的存在情况。
尽管连锁分析证实了在这些晚发型AD家庭中APOE基因位点存在遗传易感性因素,但我们无法证实靠近标记D12S1042处存在一个基因位点。在两个成员均不携带APOE ε4等位基因的患病对中,靠近α2 - 巨球蛋白基因位点的D12S98附近发现了一个中等连锁值(1.91)。
APOE仍然是唯一已确定的晚发型AD风险因素。我们无法证实在12号染色体p11 - 12区域的一个基因位点对晚发型AD风险有主要影响,尽管不能排除其影响小于APOE的可能性。